|
2021-04-28 |
2021-04-26 |
A
Achat
|
Meyers Michael L.
SVP, Chief Medical Officer
Dirigeant
|
500
+3.3%
15,46
7 730
USD
|
500
+3.3%
|
15,46
|
7 730
USD
|
|
|
2021-04-22 |
2021-04-22 |
A
Achat
|
Podlesak Dennis
Administrateur non-exécutif
|
13 967
+47.6%
14,11
197 077
USD
|
13 967
+47.6%
|
14,11
|
197 077
USD
|
|
|
2021-03-03 |
2021-03-01 |
VP
Vente planifiée
|
Egros Fabrice
Administrateur non-exécutif
|
74
-0.5%
24,31
1 799
USD
|
74
-0.5%
|
24,31
|
1 799
USD
|
|
|
2021-03-03 |
2021-03-01 |
VP
Vente planifiée
|
Egros Fabrice
Administrateur non-exécutif
|
10 167
-38.7%
24,31
247 182
USD
|
10 167
-38.7%
|
24,31
|
247 182
USD
|
|
|
2021-02-10 |
2021-02-08 |
VP
Vente planifiée
|
Morrison Briggs
Chief Executive Officer
Administrateur exécutif
|
35 156
-42.1%
20,55
722 403
USD
|
35 156
-42.1%
|
20,55
|
722 403
USD
|
|
|
2021-02-03 |
2021-02-01 |
VP
Vente planifiée
|
Metzger Michael A
President and COO
Administrateur exécutif
|
15 000
-45.9%
20,19
302 799
USD
|
15 000
-45.9%
|
20,19
|
302 799
USD
|
|
|
2020-12-03 |
2020-12-01 |
VP
Vente planifiée
|
Metzger Michael A
President and COO
Administrateur exécutif
|
15 000
-45.9%
22,97
344 513
USD
|
15 000
-45.9%
|
22,97
|
344 513
USD
|
|
|
2020-11-25 |
2020-11-23 |
V
Vente
|
Ordentlich Peter
Chief Scientific Officer
Dirigeant
|
16 334
-100.0%
22,89
373 924
USD
|
16 334
-100.0%
|
22,89
|
373 924
USD
|
|
|
2020-11-25 |
2020-11-23 |
V
Vente
|
Ordentlich Peter
Chief Scientific Officer
Dirigeant
|
7 954
-32.7%
23,58
187 594
USD
|
7 954
-32.7%
|
23,58
|
187 594
USD
|
|
|
2020-11-25 |
2020-11-23 |
V
Vente
|
Ordentlich Peter
Chief Scientific Officer
Dirigeant
|
5 684
-19.0%
23,33
132 603
USD
|
5 684
-19.0%
|
23,33
|
132 603
USD
|
|
|
2020-11-12 |
2020-11-10 |
V
Vente
|
Morrison Briggs
Chief Executive Officer
Administrateur exécutif
|
17 466
-27.3%
20,06
350 312
USD
|
17 466
-27.3%
|
20,06
|
350 312
USD
|
|
|
2020-11-12 |
2020-11-09 |
V
Vente
|
Morrison Briggs
Chief Executive Officer
Administrateur exécutif
|
62 938
-57.5%
20,04
1 261 265
USD
|
62 938
-57.5%
|
20,04
|
1 261 265
USD
|
|
|
2020-11-06 |
2020-11-04 |
VP
Vente planifiée
|
Metzger Michael A
President and COO
Administrateur exécutif
|
100 000
-85.0%
20,31
2 031 410
USD
|
100 000
-85.0%
|
20,31
|
2 031 410
USD
|
|
|
2020-02-05 |
2020-02-04 |
A
Achat
|
Morrison Briggs
Chief Executive Officer
|
12 500
+39.8%
8,00
100 000
USD
|
12 500
+39.8%
|
8,00
|
100 000
USD
|
|
|
2019-10-11 |
2019-10-10 |
A
Achat
|
Morrison Briggs
Chief Executive Officer
|
11 000
+53.9%
5,40
59 400
USD
|
11 000
+53.9%
|
5,40
|
59 400
USD
|
|
|
2019-05-13 |
2019-05-13 |
A
Achat
|
Morrison Briggs
Chief Executive Officer
|
7 200
+54.5%
7,29
52 517
USD
|
7 200
+54.5%
|
7,29
|
52 517
USD
|
|
|
2019-05-13 |
2019-05-09 |
A
Achat
|
Morrison Briggs
Chief Executive Officer
|
13 200
+inf%
7,56
99 726
USD
|
13 200
+inf%
|
7,56
|
99 726
USD
|
|
|
2019-03-22 |
2019-03-21 |
A
Achat
|
Meyers Michael L.
SVP, Chief Medical Officer
|
104
+1.5%
4,87
506
USD
|
104
+1.5%
|
4,87
|
506
USD
|
|
|
2019-03-22 |
2019-03-21 |
A
Achat
|
Meyers Michael L.
SVP, Chief Medical Officer
|
1 000
+16.3%
4,93
4 930
USD
|
1 000
+16.3%
|
4,93
|
4 930
USD
|
|
|
2018-11-07 |
2018-10-30 |
AP
Achat planifié
|
Meyers Michael L.
SVP, Chief Medical Officer
|
200
+9.1%
4,79
958
USD
|
200
+9.1%
|
4,79
|
958
USD
|
|
|
2018-04-03 |
2018-04-03 |
VP
Vente planifiée
|
Ordentlich Peter
Chief Scientific Officer
|
7 500
-100.0%
15,00
112 500
USD
|
7 500
-100.0%
|
15,00
|
112 500
USD
|
|
|
2017-05-19 |
2017-05-17 |
VP
Vente planifiée
|
Ordentlich Peter
Chief Scientific Officer
|
5 000
-100.0%
15,00
75 000
USD
|
5 000
-100.0%
|
15,00
|
75 000
USD
|
|
|
2016-03-08 |
2016-03-08 |
A
Achat
|
ROYSTON IVOR
Administrateur non-exécutif
|
150 000
+25.0%
12,00
1 800 000
USD
|
150 000
+25.0%
|
12,00
|
1 800 000
USD
|
|
